Evaluation of mutagenicity of acrylamide using RBC Pig-a and PIGRET assays by single peroral dose in rats

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 811, Issue , 2016, Pages 54-59

  Horibata, Katsuyoshi ^a   Ukai, Akiko ^a   Honma, Masamitsu ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Acrylamide; Glycosylphosphatidylinositol anchor; Pig a gene; Red blood cell; Reticulocyte

Indexed keywords

ACRYLAMIDE; MEMBRANE PROTEIN; MUTAGENIC AGENT; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; GENE; GENE MUTATION; GENOTOXICITY ASSAY; HINDLIMB; LD50; LIMB WEAKNESS; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PARALYSIS; PIG A GENE; PIGRET ASSAY; PRIORITY JOURNAL; RAT; RETICULOCYTE; RETICULOCYTOSIS; TOXICITY TESTING; WEIGHT REDUCTION; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; FISCHER 344 RAT; GENETICS; MUTAGEN TESTING; PROCEDURES;

ACRYLAMIDE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; MALE; MEMBRANE PROTEINS; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, INBRED F344; RETICULOCYTES;

EID: 84953309691     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2015.12.005     Document Type: Article

References (45)

1. [1] Miura, D., Dobrovolsky, V.N., Kimoto, T., Kasahara, Y., Heflich, R.H., Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat. Res. 677 (2009), 86–92.
2. [2] Miura, D., Dobrovolsky, V.N., Kasahara, Y., Katsuura, Y., Heflich, R.H., Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ. Mol. Mutagen. 49 (2008), 614–621.
3. [3] Miura, D., Dobrovolsky, V.N., Mittelstaedt, R.A., Kasahara, Y., Katsuura, Y., Heflich, R.H., Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ. Mol. Mutagen. 49 (2008), 622–630.
4. [4] Dertinger, S.D., Phonethepswath, S., Franklin, D., Weller, P., Torous, D.K., Bryce, S.M., Avlasevich, S., Bemis, J.C., Hyrien, O., Palis, J., MacGregor, J.T., Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol. Sci. 115 (2010), 401–411.
5. [5] Shi, J., Krsmanovic, L., Bruce, S., Kelly, T., Paranjpe, M., Szabo, K., Arevalo, M., Atta-Safoh, S., Debelie, F., LaForce, M.K., Sly, J., Springer, S., Assessment of genotoxicity induced by 7,12-dimethylbenz(a) anthracene or diethylnitrosamine in the Pig-a, micronucleus and comet assays integrated into 28-day repeat dose studies. Environ. Mol. Mutagen. 52 (2011), 711–720.
6. [6] Stankowski, L.F., Roberts, D.J., Chen, H., Lawlor, T., McKeon, M., Murli, H., Thakur, A., Xu, Y., Integration of Pig-a, micronucleus, chromosome aberration, and comet assay endpoints in a 28-day rodent toxicity study with 4-nitroquinoline-1-oxide. Environ. Mol. Mutagen. 52 (2011), 738–747.
7. [7] Dertinger, S.D., Phonethepswath, S., Weller, P., Avlasevich, S., Torous, D.K., Mereness, J.A., Bryce, S.M., Bemis, J.C., Bell, S., Portugal, S., Aylott, M., MacGregor, J.T., Interlaboratory Pig-a gene mutation assay trial: studies of 1,3-propane sultone with immunomagnetic enrichment of mutant erythrocytes. Environ. Mol. Mutagen. 52 (2011), 748–755.
8. [8] Horibata, K., Ukai, A., Kimoto, T., Suzuki, T., Kamoshita, N., Masumura, K., Nohmi, T., Honma, M., Evaluation of in vivo genotoxicity induced by N-ethyl-N-nitrosourea, benzo[a]pyrene, and 4-nitroquinoline-1-oxide in the Pig-a and gpt assays. Environ. Mol. Mutagen. 54 (2013), 747–754.
9. [9] Lynch, A.M., Giddings, A., Custer, L., Gleason, C., Henwood, A., Aylott, M., Kenny, J., International Pig-a gene mutation assay trial (stage III): results with N-methyl-N-nitrosourea. Environ. Mol. Mutagen. 52 (2011), 699–710.
10. [10] Dobrovolsky, V.N., Boctor, S.Y., Twaddle, N.C., Doerge, D.R., Bishop, M.E., Manjanatha, M.G., Kimoto, T., Miura, D., Heflich, R.H., Ferguson, S.A., Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats. Environ. Mol. Mutagen. 51 (2010), 138–145.
11. [11] Horibata, K., Ukai, A., Koyama, N., Takagi, A., Kanno, J., Kimoto, T., Miura, D., Hirose, A., Honma, M., Fullerene (C60) is negative in the in vivo Pig-A gene mutation assay. Genes Environ. 33 (2011), 27–31.
12. [12] Phonethepswath, S., Franklin, D., Torous, D.K., Bryce, S.M., Bemis, J.C., Raja, S., Avlasevich, S., Weller, P., Hyrien, O., Palis, J., Macgregor, J.T., Dertinger, S.D., Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol. Sci. 114 (2010), 59–70.
13. [13] Cammerer, Z., Bhalli, J.A., Cao, X., Coffing, S.L., Dickinson, D., Dobo, K.L., Dobrovolsky, V.N., Engel, M., Fiedler, R.D., Gunther, W.C., Heflich, R.H., Pearce, M.G., Shaddock, J.G., Shutsky, T., Thiffeault, C.J., Schuler, M., Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea—comparison with other in vivo genotoxicity endpoints. Environ. Mol. Mutagen. 52 (2011), 721–730.
14. [14] Bhalli, J.A., Shaddock, J.G., Pearce, M.G., Dobrovolsky, V.N., Cao, X., Heflich, R.H., Vohr, H.-W., Report on stage III Pig-a mutation assays using benzo[a]pyrenert. Environ. Mol. Mutagen. 52 (2011), 731–737.
15. [15] Kimoto, T., Chikura, S., Suzuki, K., Kobayashi, X.m., Itano, Y., Horibata, K., Honma, M., Dobrovolsky, V.N., Heflich, R.H., Miura, D., Kasahara, Y., Further development of the rat Pig-a mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes. Environ. Mol. Mutagen. 52 (2011), 774–783.
16. [16] Kimoto, T., Horibata, K., Chikura, S., Hashimoto, K., Itoh, S., Sanada, H., Muto, S., Uno, Y., Yamada, M., Honma, M., Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. Mutat. Res. 755 (2013), 126–134.
17. [17] Sanada, H., Okamoto, M., Ohsumi, T., Nakamura, T., Evaluation for a mutagenicity of 4,4'-methylenedianiline on hematopoietic cells by a Pig-a gene mutation assay in rats. Genes Environ. 36 (2014), 179–185.
18. [18] Muto, S., Yamada, K., Kato, T., Iwase, Y., Uno, Y., Pig-a gene mutation and micronucleus induction in rat peripheral blood by methyl methanesulfonate. Genes Environ. 36 (2014), 186–190.
19. [19] Kimoto, T., Chikura, S., Suzuki-Okada, K., Kobayashi, X., Itano, Y., Miura, D., Kasahara, Y., The rat Pig-a mutation assay in single and 28 day-repeated dose study of cyclophosphamide: the PIGRET assay can detect the in vivo mutagenicity earlier than the RBC Pig-a assay. Genes Environ. 36 (2014), 191–198.
20. [20] Itoh, S., Nagata, M., Hattori, C., Takasaki, W., In vivo mutagenicity of ethyl methanesulfonate detected by Pig-a and PIGRET assays. Genes Environ. 36 (2014), 174–178.
21. [21] Horibata, K., Ukai, A., Honma, M., Evaluation of rats' in vivo genotoxicity induced by N-ethyl-N-nitrosourea in the RBC Pig-a, PIGRET, and gpt assays. Genes Environ. 36 (2014), 199–202.
22. [22] Acrylamide, I.A.R.C., IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans: Some Industrial Chemicals. 1994, International Agency for Research on Cancer, Lyon, 389–433.
23. [23] Abramsson-Zetterberg, L., The dose-response relationship at very low doses of acrylamide is linear in the flow cytometer-based mouse micronucleus assay. Mutat. Res. 535 (2003), 215–222.
24. [24] Cao, J., Beisker, W., Nusse, M., Adler, I.D., Flow cytometric detection of micronuclei induced by chemicals in poly- and normochromatic erythrocytes of mouse peripheral blood. Mutagenesis 8 (1993), 533–541.
25. [25] Manjanatha, M.G., Aidoo, A., Shelton, S.D., Bishop, M.E., McDaniel, L.P., Lyn-Cook, L.E., Doerge, D.R., Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ. Mol. Mutagen. 47 (2006), 6–17.
26. [26] Ghanayem, B.I., Witt, K.L., Kissling, G.E., Tice, R.R., Recio, L., Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat. Res. 578 (2005), 284–297.
27. [27] Mei, N., McDaniel, L.P., Dobrovolsky, V.N., Guo, X., Shaddock, J.G., Mittelstaedt, R.A., Azuma, M., Shelton, S.D., McGarrity, L.J., Doerge, D.R., Heflich, R.H., The genotoxicity of acrylamide and glycidamide in big blue rats. Toxicol. Sci. 115 (2010), 412–421.
28. [28] Koyama, N., Yasui, M., Kimura, A., Takami, S., Suzuki, T., Masumura, K., Nohmi, T., Masuda, S., Kinae, N., Matsuda, T., Imai, T., Honma, M., Acrylamide genotoxicity in young versus adult gpt delta male rats. Mutagenesis 26 (2011), 545–549.
29. [29] Ishii, Y., Matsushita, K., Kuroda, K., Yokoo, Y., Kijima, A., Takasu, S., Kodama, Y., Nishikawa, A., Umemura, T., Acrylamide induces specific DNA adduct formation and gene mutations in a carcinogenic target site, the mouse lung. Mutagenesis 30 (2015), 227–235.
30. [30] Maniere, I., Godard, T., Doerge, D.R., Churchwell, M.I., Guffroy, M., Laurentie, M., Poul, J.M., DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide. Mutat. Res. 580 (2005), 119–129.
31. [31] Rice, J.M., The carcinogenicity of acrylamide. Mutat. Res. 580 (2005), 3–20.
32. [32] Sumner, S.C., Fennell, T.R., Moore, T.A., Chanas, B., Gonzalez, F., Ghanayem, B.I., Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chemi. Res. Toxicol. 12 (1999), 1110–1116.
33. [33] Ghanayem, B.I., McDaniel, L.P., Churchwell, M.I., Twaddle, N.C., Snyder, R., Fennell, T.R., Doerge, D.R., Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 88 (2005), 311–318.
34. [34] Kotova, N., Juren, T., Myohanen, K., Cornelius, M., Abramsson-Zetterberg, L., Backman, J., Menzel, U., Rydberg, P., Kronberg, L., Vahakangas, K., Segerback, D., (3)(2)P-HPLC analysis of N1-(2-carboxy-2-hydroxyethyl) deoxyadenosine: a DNA adduct of the acrylamide-derived epoxide glycidamide. Toxicol. Lett. 207 (2011), 18–24.
35. [35] Segerback, D., Calleman, C.J., Schroeder, J.L., Costa, L.G., Faustman, E.M., Formation of N-7-(2-carbamoyl-2-hydroxyethyl) guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 16 (1995), 1161–1165.
36. [36] Gamboa da Costa, G., Churchwell, M.I., Hamilton, L.P., Von Tungeln, L.S., Beland, F.A., Marques, M.M., Doerge, D.R., DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem. Res. Toxicol. 16 (2003), 1328–1337.
37. [37] Koyama, N., Sakamoto, H., Sakuraba, M., Koizumi, T., Takashima, Y., Hayashi, M., Matsufuji, H., Yamagata, K., Masuda, S., Kinae, N., Honma, M., Genotoxicity of acrylamide and glycidamide in human lymphoblastoid TK6 cells. Mutat. Res. 603 (2006), 151–158.
38. [38] Koyama, N., Yasui, M., Oda, Y., Suzuki, S., Satoh, T., Suzuki, T., Matsuda, T., Masuda, S., Kinae, N., Honma, M., Genotoxicity of acrylamide in vitro: acrylamide is not metabolically activated in standard in vitro systems. Environ. Mol. Mutagen. 52 (2011), 11–19.
39. [39] Dobrovolsky, V.N., et al. In vivo genotoxicity assessment of acrylamide and glycidyl methacrylate. Food Chem. Toxicol. 87 (2016), 120–127.
40. [40] Gollapudi, B.B., Lynch, A.M., Heflich, R.H., Dertinger, S.D., Dobrovolsky, V.N., Froetschl, R., Horibata, K., Kenyon, M.O., Kimoto, T., Lovell, D.P., Stankowski, L.F., White, P.A., Witt, K.L., Tanir, J.Y., The in vivo Pig-a assay: a report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup. Mutat. Res. 783 (2015), 23–35.
41. [41] Kimoto, T., et al. The PIGRET assay, a method for measuring Pig-a gene mutation in reticulocytes, is reliable as a short-term in vivo genotoxicity test: summary of the MMS/JEMS-collaborative study across 16 laboratoriesusing 24 chemicals. Mutat. Res. 811 (2016), 3–15.
42. [42] Tilson, H.A., Cabe, P.A., The effects of acrylamide given acutely or in repeated doses on fore- and hindlimb function of rats. Toxicol. Appl. Pharmacol. 47 (1979), 253–260.
43. [43] Dertinger, S.D., Bryce, S.M., Phonethepswath, S., Avlasevich, S.L., When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis. Mutat. Res. 721 (2011), 163–170.
44. [44] Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T., Kinoshita, T., Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73 (1993), 703–711.
45. [45] Hu, R., Mukhina, G.L., Piantadosi, S., Barber, J.P., Jones, R.J., Brodsky, R.A., PIG-A mutations in normal hematopoiesis. Blood 105 (2005), 3848–3854.